Preventative antibiotics halve the risk of infection in childbirth
NIHR trial finds that a single dose of preventative prophylactic antibiotics, halves the risk of infection for women who have assisted vaginal births.
- Published: 14 September 2020
Case studies
Latest case studies
Filter results
Latest case studies
Empowering individuals to take action against type 2 diabetes
A dramatic 800 calorie a day diet that has been shown to reverse diabetes is currently being piloted in the NHS across England. This follows a successful NIHR-funded trial that showed the effectiveness of the liquid diet and a larger trial into how the diet could be rolled out into everyday practice.
- Published: 11 September 2020
Childhood respiratory virus diagnosis without delay
A quick bedside test can deliver diagnosis of respiratory virus infection in children and allow clinicians to treat patients while protecting others from infection. Results from recent trials could change care pathways in the future.
- Published: 17 August 2020
Efficient and effective vaccination against pneumococcal disease
It is possible to reduce the number of pneumococcal vaccines given to babies and children without increasing their risk of serious and fatal infections. An NIHR-funded trial demonstrated that fewer injections can deliver immunity in the UK, leading to the government changing the pneumococcal vaccine schedule from three doses to two.
- Published: 04 August 2020
Digital test provides quick and clear data for ADHD diagnosis
A 20 minute measurement test for Attention Deficit Hyperactivity Disorder (ADHD) has transformed the experience of patients and clinicians across the East Midlands and is being rolled out across the country.
- Published: 29 April 2020
Chipping away at portion sizes
Researchers funded by the NIHR School for Public Health Research explored how working with a wholesale supplier could encourage fish and chip shops to offer smaller portion sizes to customers.
- Published: 19 August 2019
Hope for stroke patients with aphasia
NIHR researchers compare self-managed computer therapy programme to usual speech and language therapy
- Published: 01 July 2019
Cheaper AMD drug could save NHS millions
Avastin, a drug that treats neovascular age-related macular degeneration, could save the NHS millions
- Published: 16 June 2019
Treatments for broken bones
The NIHR-funded WOLLF study set out to find the best wound dressing for open fractures.
- Published: 16 June 2019
Improving safety for people who inject drugs
NIHR researchers have worked with people who inject drugs to understand their views on new, safer equipment, helping to increase the adoption of this equipment across the UK
- Published: 15 June 2019
Improving treatment for advanced prostate cancer
The NIHR-supported trial, STAMPEDE, set out find the best way of treating men with high risk prostate cancer by assessing the effect of a range of new treatments.
- Published: 14 June 2019
Virtual reality for mental health
The NIHR is investing in developing new ways to use technology to help people affected by mental health disorders
- Published: 14 June 2019
New independence for people with neurodegenerative diseases
The NIHR funds the development and testing of novel medical technologies that can change the lives of patients
- Published: 12 June 2019
Curing the most common form of blindness
NIHR Biomedical Research Centres are leading the way in developing innovative new techniques to treat age-related macular degeneration and restore vision.
- Published: 02 April 2019
Beating the bugs
The NIHR has committed over £100 million into research addressing the use of antimicrobial drugs such as antibiotics to help tackle antimicrobial resistance.
- Published: 02 April 2019
Living well with dementia
The IDEAL study the first large-scale project of its kind to investigate what factors can be targeted to support people to live well with dementia.
- Published: 02 April 2019
Treating multiple myeloma
NIHR research into myeloma includes clinical trials testing innovative new drugs which may have therapeutic benefit for patients.
- Published: 02 April 2019